|
⚠️ Professional Use Only This content is intended exclusively for licensed medical professionals. It does not constitute clinical advice. Always follow applicable regulations and guidelines in your jurisdiction. |
|
✍️ Written by: Celmade Editorial Team | AI-Assisted Content 🔬 Medically Reviewed by: Stella Williams, Medical Aesthetic Injector 📅 Published: April 29th, 2026 | Last Reviewed: April 29th, 2026 🔗 View Reviewer Full Profile → celmade.co/pages/team-stella-williams |
|
📌 Editorial Note: This article was drafted with AI assistance and reviewed, fact-checked, and approved by Stella Williams, a qualified Medical Aesthetic Injector. All clinical claims are supported by cited references. |
Laser resurfacing and energy device treatments represent some of the most powerful tools in non-surgical aesthetic medicine — producing collagen remodelling, surface renewal, and tissue tightening outcomes that injectable treatments alone cannot replicate. But they also represent significant tissue stressors: ablative procedures breach the skin barrier, non-ablative procedures create controlled thermal injury, and all of them initiate an inflammatory and wound healing cascade that, while therapeutic, imposes a physiological burden on the treated tissue.

PDRN (polydeoxyribonucleotide) is one of the few injectable agents that is mechanistically well-matched to support this tissue response. Its adenosine A2A receptor activation drives the same wound healing cascade that laser and energy procedures initiate — but from the biological inside rather than through physical injury. The anti-inflammatory, pro-angiogenic, and fibroblast-stimulating effects of PDRN align precisely with what treated tissue needs in the recovery and remodelling phases after an energy procedure.
This guide covers the complete framework for combining PDRN with laser and energy devices: the biological rationale, timing intervals for each device category, before and after protocols, and the combination approaches that produce the best outcomes. For the full PDRN clinical background, see the Complete Practitioners Guide to Polynucleotides and PDRN.
Why PDRN and Energy Devices Are Clinically Complementary
The synergy between PDRN and energy devices is not simply additive — it is mechanistically logical. Understanding why they work together so well helps practitioners design combination protocols with scientific confidence:
Energy Devices: The Physical Stimulus
Laser resurfacing, RF microneedling, HIFU, and other energy devices produce their clinical effects by creating controlled tissue injury or stress that triggers a healing and remodelling response. The primary mechanisms:
• Ablative laser (CO2, erbium): Removes layers of the epidermis and superficial dermis. Creates a precise wound that heals through re-epithelialisation, collagen contraction (immediate), and new collagen synthesis (over 3–6 months). The most powerful non-surgical resurfacing tool.
• Non-ablative fractional laser (1550nm, 1927nm): Creates thousands of microscopic thermal columns in the dermis without breaking the skin surface. Each column heals through collagen remodelling over several months while surrounding undamaged tissue supports recovery.
• RF microneedling (Morpheus, Profound, Scarlet): Combines microneedle mechanical injury with radiofrequency energy delivered at the needle tips. Creates both dermal collagen induction from the needles and collagen contraction from the thermal RF energy. Effective for laxity, scars, and skin quality.
• HIFU (High-Intensity Focused Ultrasound): Delivers focused ultrasound energy to the SMAS layer and deep dermis, creating thermal coagulation points that stimulate collagen remodelling and tissue tightening over 3–6 months. Does not breach the skin surface.
• IPL (Intense Pulsed Light): Targets chromophores (melanin, oxyhaemoglobin) to address pigmentation and vascular lesions. Also stimulates some degree of collagen remodelling through thermal dermal stimulation. Less invasive than laser resurfacing.
PDRN: The Biological Amplifier
Where energy devices create the injury signal, PDRN amplifies the biological response:
• A2AR anti-inflammatory effect: Energy device procedures produce acute post-treatment inflammation — redness, swelling, and discomfort. PDRN's adenosine A2A receptor activation suppresses pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), reducing the inflammatory burden and shortening the acute recovery phase.
• VEGF-mediated angiogenesis: The remodelling tissue after laser or RF treatment has increased metabolic demands — new collagen synthesis is energy-intensive. PDRN's VEGF upregulation promotes new capillary formation that improves oxygen and nutrient delivery to the tissue during remodelling.
• Fibroblast proliferation amplification: Energy devices stimulate fibroblasts through the wound healing cascade. PDRN provides an additional direct A2AR-mediated stimulus to fibroblast proliferation and collagen synthesis, amplifying the remodelling response beyond what the device alone produces.
• Salvage pathway nucleotide supply: Rapidly proliferating fibroblasts in the post-procedure remodelling phase have high demand for DNA and RNA building blocks. PDRN metabolites enter the salvage pathway and directly supply these building blocks, supporting the energy-intensive collagen synthesis process.
|
The combined result: Energy device + PDRN = Physical injury stimulus + Biological amplification of the wound healing response. The device creates the trigger; PDRN provides the biological environment in which the response is maximised. The combination consistently produces better outcomes than either treatment alone — with the added benefit of shorter recovery time from PDRN's anti-inflammatory effect. |
The Core Timing Principle: Phase-Matched Treatment
The most important concept in combining PDRN with energy devices is matching the PDRN timing to the relevant phase of the wound healing response. Energy device procedures initiate a healing cascade with three overlapping phases:
|
Healing Phase |
Timing |
What Is Happening |
PDRN's Role in This Phase |
Appropriate to Inject? |
|
Inflammatory phase |
Hours to Day 3–5 post-procedure |
Vasodilation, oedema, neutrophil infiltration, cytokine signalling. Redness, swelling, and discomfort are normal. The skin barrier is compromised in ablative procedures. |
Anti-inflammatory A2AR effect is most valuable here — but the compromised skin surface makes intradermal injection contraindicated in ablative procedures during this phase. |
No for ablative. Yes for topical PDRN product via open channels immediately post non-ablative microneedling. No for injectable in any procedure during acute inflammatory phase. |
|
Proliferative / repair phase |
Days 5 to Week 4–6 |
Fibroblast proliferation, new collagen synthesis, re-epithelialisation (ablative). The most active healing period. Skin is healing but the surface is still in recovery. |
Fibroblast stimulation and nucleotide supply are most impactful during active collagen synthesis. This is when PDRN adds most biological value — but injection timing depends on whether the surface has fully healed. |
Yes for ablative once fully re-epithelialised (typically week 4–6+). Yes for non-ablative from week 2 onward. Yes for HIFU/RF from week 2 onward. |
|
Remodelling phase |
Weeks 4 to Month 12+ |
Collagen fibre organisation, cross-linking, scar maturation (for scars). Long-term improvement continues. The slowest and most sustained phase. |
Periodic PDRN during this phase sustains fibroblast activity and maintains the improved tissue environment. Particularly valuable for patients seeking maximum collagen remodelling from their laser investment. |
Yes — from appropriate post-procedure interval onward. Ideal maintenance during 6–12 month remodelling window. |
Device-by-Device Combination Protocols
Each energy device category has specific combination parameters determined by the degree of tissue disruption it creates:
Ablative Fractional Laser (CO2 and Erbium YAG)
The highest-intensity resurfacing devices. Full ablative CO2 removes the entire epidermis and superficial dermis; fractional ablative treats a percentage of the surface with spared tissue between treatment zones. Both create skin barrier breach requiring careful timing:
|
Timing Point |
Protocol |
Rationale |
|
Pre-laser (4–6 weeks before) |
PDRN course — 1–2 sessions to optimise baseline skin quality and collagen status before the procedure |
Improved baseline skin quality and collagen density before laser creates a better tissue environment for the laser procedure and may improve the quality of the healing response |
|
Immediately post-laser |
No injectable PDRN. Topical wound healing protocol only (emollients, gentle cleansing, SPF once healed). |
Skin barrier is breached. Injecting through compromised skin creates infection risk and introduces product into acutely wounded tissue. |
|
Week 1–3 post-laser |
No injectable PDRN. Continue topical care. |
Acute inflammatory phase and early re-epithelialisation. Focus is on wound healing support, not additional biological stimulation. |
|
Week 4–6 post-laser (first injectable PDRN) |
Confirm skin is fully re-epithelialised (no open areas, normal skin surface texture). First PDRN session — full face nappage at standard protocol. |
The skin is now healed and the active collagen synthesis phase is underway. PDRN at this point amplifies the ongoing remodelling response. |
|
Week 8–12 (second PDRN session) |
Second PDRN session. Photograph for mid-course comparison. |
Second A2AR stimulus during the ongoing remodelling phase. Cumulative fibroblast support across the 3–6 month remodelling window. |
|
Month 3–6 (maintenance PDRN) |
PDRN session every 4–6 weeks or monthly during the 6-month remodelling window, depending on patient goals. |
Sustained biological support during the long-term collagen maturation phase. Maximises the long-term investment in the laser procedure. |
|
Key rule for ablative laser: Never inject PDRN — or any injectable product — through skin that has not fully re-epithelialised after ablative laser resurfacing. The minimum interval is 4 weeks; for full-ablative CO2, wait until the treating practitioner confirms the skin is fully healed. Earlier injection introduces infection risk and cannot be justified by any clinical benefit claim. |
Non-Ablative Fractional Laser (1550nm, 1927nm Fraxel and equivalents)
Non-ablative fractional laser creates microscopic thermal zones within the dermis without removing the surface epidermis. The skin surface remains intact, which changes the safety window for PDRN injection:
|
Timing Point |
Protocol |
Rationale |
|
Pre-procedure (4–6 weeks before) |
1–2 PDRN sessions to optimise skin quality and collagen baseline |
As for ablative laser — improved baseline amplifies the procedure response |
|
Day 0 (same day, post-procedure) |
No injectable PDRN. Topical cooling and gentle care. |
Even without skin surface breach, the acute inflammatory response from thermal zones warrants a rest period before additional biological stimulus. |
|
Week 1–2 post-procedure |
No injectable PDRN. Allow acute inflammation to resolve. |
Post-procedure erythema and swelling resolving. Microscopic healing zones completing their acute repair. |
|
Week 2–3 (first injectable PDRN) |
PDRN session — intradermal nappage across the treated zone. |
The skin surface is intact; acute phase is resolved. PDRN from week 2 onward is safe and provides biological amplification during the active proliferative phase. |
|
Month 1–6 (maintenance PDRN) |
Monthly or 6-weekly PDRN sessions during the remodelling window. |
Sustained support during the long-term collagen remodelling phase initiated by the laser. |
RF Microneedling (Morpheus8, Profound, Scarlet RF, Potenza)
RF microneedling combines physical needle channels with radiofrequency thermal energy. It creates both surface micro-punctures and subsurface thermal injury, requiring a moderate safety interval before PDRN injection:
|
Timing Point |
Protocol |
Rationale |
|
Same session — topical PDRN only |
Topical PDRN serum applied to the skin immediately after RF microneedling, while microchannels are open |
PDRN penetrates via the microchannels without injection. Avoids any infection risk from injecting through open channels while delivering PDRN to the dermis. |
|
Day 0–3 |
No injectable PDRN. Topical wound care. |
Acute inflammatory phase — microchannels may still be partially open for 24–48 hours. |
|
Week 1–2 |
No injectable PDRN. Allow surface to recover fully. |
Microchannels closed; acute inflammation resolving. |
|
Week 3–4 (first injectable PDRN) |
PDRN intradermal session — standard nappage protocol. |
Channels fully healed. Injectable PDRN from week 3–4 provides the maximum intradermal PDRN delivery as an amplifier to the RF-stimulated remodelling response. |
|
Month 2–6 (maintenance) |
Monthly or 6-weekly PDRN sessions. |
Sustained support during the extended RF collagen remodelling and contraction phase. |
|
The topical PDRN same-session approach: Applying topical PDRN product to the skin immediately after RF microneedling — while the microchannels are still open — is an increasingly popular approach in practices that have both modalities. The PDRN reaches the dermis via the channels without any injection needle, providing biological support to the fresh collagen induction stimulus at exactly the moment when the wound healing cascade is being activated. Use a sterile PDRN product formulated for topical application post-procedure — not an injectable product applied topically. |
HIFU (High-Intensity Focused Ultrasound: Ultherapy, Doublo, SMAS-targeting devices)
HIFU delivers focused ultrasound energy to the SMAS layer and deep dermis without breaching the skin surface. The skin surface remains completely intact, making the PDRN timing more flexible:
|
Timing Point |
Protocol |
Rationale |
|
Same session or within 1 week post-HIFU |
Injectable PDRN is safe from the same session or shortly after, as the skin surface is intact |
No skin barrier breach. PDRN addresses the inflammatory response from deep tissue HIFU effects and supports collagen remodelling from week 1. |
|
Month 1–6 (remodelling phase) |
Monthly or 6-weekly PDRN sessions during the HIFU collagen remodelling window. |
HIFU produces its primary tightening effect from collagen contraction and remodelling over 3–6 months. PDRN amplifies the fibroblast activity during this window. |
|
6 months post-HIFU |
Assess HIFU result. Repeat HIFU if indicated. Continue PDRN maintenance. |
HIFU effects plateau at 6 months. Assessment point for deciding on a repeat HIFU treatment. PDRN maintenance continues regardless. |
IPL (Intense Pulsed Light) and Vascular Laser
IPL and vascular lasers (including 532nm KTP, 585nm pulsed dye) target chromophores without creating significant collagen induction wound healing. The skin surface is generally preserved, and the primary use case for post-IPL PDRN is supporting the skin quality improvement alongside the chromophore-targeting effect:
|
Timing Point |
Protocol |
Rationale |
|
Week 1–2 post-IPL |
No injectable PDRN. Allow acute crusting, erythema, and pigment clearance to proceed. |
Post-IPL skin is sensitised. Brief rest period before PDRN injection. |
|
Week 2 onward |
PDRN intradermal session — standard nappage. |
IPL addresses pigmentation and vascularity; PDRN addresses the skin quality and collagen dimension that IPL alone cannot reach. The combination provides both chromophore targeting and skin quality improvement. |
Microneedling (Standard, without RF)
Standard microneedling (Dermapen, Dermaroller) without RF energy is the most accessible device for most aesthetic practitioners and the most commonly used device in combination with PDRN. For the full microneedling + PDRN protocol, see the relevant section of our PDRN for Acne Scars guide. Key timing:
• Same session — topical PDRN: Apply topical PDRN immediately post-microneedling via open channels. Effective and safe.
• Injectable PDRN: Minimum 2 weeks after microneedling, when microchannels are fully closed.
• Alternating session approach: Microneedling session 1, PDRN injection session 2 (2–4 weeks later) — alternating through the induction course.
Master Timing Reference: All Devices at a Glance
|
Device / Procedure |
Skin Barrier? |
Earliest Injectable PDRN |
Same-Session Topical PDRN? |
PDRN Role Pre-Procedure |
PDRN Role Post-Procedure |
|
Ablative CO2 laser (full) |
Breached — full ablation |
Week 6+ (fully re-epithelialised) |
No — topical wound care only |
1–2 sessions 4–6 weeks pre-laser for baseline optimisation |
Biological amplification of remodelling from week 6. Monthly sessions through 6-month window. |
|
Ablative erbium laser |
Breached — less deeply than CO2 |
Week 4–5 (re-epithelialised) |
No |
1–2 sessions 4–6 weeks pre-procedure |
Amplification from week 4–5. Monthly through 6-month window. |
|
Non-ablative fractional (1550nm) |
Intact — no surface breach |
Week 2 |
No (no open channels) |
1–2 sessions 4–6 weeks pre-procedure |
Amplification from week 2. Monthly through 6-month window. |
|
RF microneedling |
Micro-punctures + thermal |
Week 3–4 injectable. Day 0 topical. |
Yes — immediately post-procedure |
1–2 sessions 4–6 weeks pre-procedure |
Topical same-day. Injectable from week 3–4. Monthly through 6-month window. |
|
HIFU |
Intact — no surface breach |
Same session or week 1 |
No (no open channels) |
Optional — 1 session pre-HIFU |
From week 1. Monthly through 6-month remodelling window. |
|
Standard microneedling |
Micro-punctures only |
Week 2 injectable. Day 0 topical. |
Yes — immediately post-procedure |
Optional pre-course session |
Topical same-day. Injectable alternating sessions from week 2. |
|
IPL / Vascular laser |
Intact or minor surface effect |
Week 2 |
No |
Optional pre-course session for baseline |
From week 2 alongside IPL course for skin quality improvement. |
|
Chemical peel (superficial) |
Intact / mild disruption |
Week 2 |
No |
Optional |
Week 2 onward for skin quality support. |
|
Chemical peel (medium-deep) |
Significant disruption |
Week 4–6 (healed) |
No |
1 session 4–6 weeks pre-peel |
Week 4–6 for accelerated remodelling support. |
Sample Combination Protocol Examples
The following illustrate how PDRN is integrated into real-world energy device treatment plans:
Protocol A: Fractional CO2 Resurfacing + PDRN for Photoageing and Acne Scars
|
Stage |
Timing |
Treatments |
|
Preparation |
Week −6 to −4 |
2 × PDRN induction sessions — full face. Optimise baseline skin quality and collagen status pre-laser. |
|
Fractional CO2 laser |
Week 0 |
Fractional CO2 resurfacing by laser practitioner (or same practitioner if qualified). Standard post-laser topical care. |
|
Early recovery |
Weeks 1–4 |
Topical wound care only. No injectables. Emollient, gentle cleansing, SPF. |
|
PDRN Session 1 post-laser |
Week 5–6 (confirm re-epithelialised) |
Full face PDRN nappage at standard protocol. First biological amplification of ongoing remodelling. |
|
PDRN Session 2 |
Week 9–10 |
PDRN session. Photography comparison with pre-laser baseline. |
|
PDRN Session 3 |
Week 13–14 |
PDRN session. Combine with skin quality assessment and full photography review. |
|
Remodelling phase maintenance |
Monthly or 6-weekly to Month 6 |
PDRN maintenance sessions. Maximum laser result amplification. |
|
6-month assessment |
Month 6 |
Full photography review. Scar grading reassessment. Plan further treatment if needed. |

Protocol B: RF Microneedling + PDRN for Skin Laxity and Quality
|
Stage |
Timing |
Treatments |
|
RF Microneedling Session 1 |
Week 0 |
RF microneedling to face and neck. Topical PDRN applied immediately post-procedure via microchannels. |
|
Injectable PDRN Session 1 |
Week 3–4 |
Full face injectable PDRN nappage. First injectable amplification of RF-stimulated collagen remodelling. |
|
RF Microneedling Session 2 |
Week 6–8 |
Second RF microneedling session. Topical PDRN immediately post-procedure. |
|
Injectable PDRN Session 2 |
Week 9–10 |
PDRN injection session. Photography comparison with baseline. |
|
RF Microneedling Session 3 (if planned) |
Week 12–14 |
Third RF microneedling session. Topical PDRN immediately post-procedure. |
|
Injectable PDRN maintenance |
Monthly from Week 15 |
PDRN maintenance supporting the ongoing RF collagen remodelling. Continue monthly for 6 months post-final RF session. |
Protocol C: HIFU + PDRN for Non-Surgical Lifting
|
Stage |
Timing |
Treatments |
|
HIFU procedure |
Week 0 |
HIFU to face, neck, and brow lifting zones. |
|
PDRN Session 1 |
Week 1–2 |
Full face PDRN injectable session. HIFU surface is intact — no delay required. PDRN begins amplifying the deep tissue HIFU response from the first week. |
|
PDRN Session 2 |
Week 5–6 |
PDRN session. Begin to see early HIFU results alongside improved skin quality from PDRN course. |
|
PDRN Session 3 |
Week 9–10 |
PDRN session. |
|
PDRN Maintenance |
Monthly to Month 6 |
Monthly PDRN through the 6-month HIFU remodelling window. HIFU peaks at 6 months — PDRN supports this entire remodelling arc. |
|
6-month HIFU review |
Month 6 |
Assess HIFU + PDRN combined outcome. Plan repeat HIFU if indicated. Continue PDRN on maintenance schedule. |
Communicating the PDRN + Energy Device Combination to Patients
Patients who have invested significantly in a laser or energy device procedure are receptive to the idea of supporting their investment with a complementary biological treatment — but the communication needs to be framed correctly:
|
Suggested patient explanation for post-laser PDRN: "The laser treatment you've just had works by creating a very controlled injury to your skin, which triggers your body's own healing and collagen-building response. That healing process is what produces the improvement — and it continues for months after the procedure. The PDRN treatment I'm recommending works with this process. Think of it as giving your skin's healing system a biological boost — it directly stimulates the same collagen-producing cells that the laser is already activating. The result is a better, faster recovery and more collagen produced during the months of remodelling that follow. Most patients who combine the two treatments tell me they're really glad they did — they feel their laser investment has gone further than they expected." |
Commercial Considerations: PDRN as a High-Value Add-On
For practices that offer laser or energy device treatments, PDRN is one of the most naturally positioned and highest-value add-on treatments available. The commercial logic is straightforward:
• Protects the patient's laser investment: A patient who has spent £800–£3,000 on fractional laser or HIFU is motivated to maximise the outcome of that investment. PDRN, framed as 'investment protection' that amplifies and extends the laser result, is a highly compelling proposition at this price point.
• Creates a course of treatment — not a single appointment: A PDRN + laser combination protocol involves multiple appointments across 6 months. Each appointment generates revenue and maintains the patient relationship in the practice during the critical post-procedure period.
• Korean PDRN provides excellent margin: At 30–60% lower wholesale cost than European PN alternatives, Korean CE-marked PDRN from Celmade's PDRN and PN range provides strong margin at patient-facing prices competitive with the broader PDRN market.
• Positions the practice as a comprehensive care provider: A practice that offers not just the device procedure but a medically-supported recovery and remodelling programme distinguishes itself from practices offering device treatments alone.
Key Takeaways
• PDRN and energy devices are mechanistically complementary — devices create the physical stimulus; PDRN amplifies the biological healing and remodelling response.
• Timing is the critical variable — never inject through a compromised skin surface. For ablative laser, wait minimum 4–6 weeks for full re-epithelialisation before injectable PDRN.
• HIFU and non-ablative procedures allow the earliest PDRN injection — from the same session (HIFU) or week 2 (non-ablative fractional). Intact skin surface removes the primary safety constraint.
• Topical PDRN immediately post-microneedling and RF microneedling — applying topical PDRN via open microchannels immediately post-procedure delivers biological amplification at the precise moment the wound healing cascade is initiated.
• Pre-procedure PDRN optimises the baseline — 1–2 sessions 4–6 weeks before any ablative or high-intensity energy procedure improves the skin quality foundation and may improve the quality of the healing response.
• Monthly PDRN through the 6-month remodelling window — maximises the return from the laser or energy device investment by sustaining fibroblast activity during the long-term collagen maturation phase.
• Korean PDRN products support these protocols effectively — CE-marked, MFDS-approved products from Celmade's PDRN and PN range provide consistent pharmaceutical-grade PDRN appropriate for post-procedure combination protocols.
For related guides: Complete Polynucleotides and PDRN Guide, PDRN for Acne Scars, PDRN vs HA Skin Boosters, and Combining Skin Boosters with Other Treatments. Browse Celmade's PDRN and PN collection.
Frequently Asked Questions
Can I inject PDRN immediately after laser resurfacing?
No — not after ablative laser. The minimum interval is 4–6 weeks after ablative CO2 or erbium laser resurfacing, and only once the skin is fully re-epithelialised. Injecting through compromised skin creates infection risk and cannot be justified by any clinical benefit at this stage. For non-ablative procedures (HIFU, non-ablative fractional laser), PDRN injection is safe from week 2 onward as the skin surface is intact. For RF microneedling and standard microneedling, topical PDRN can be applied immediately post-procedure via the microchannels; injectable PDRN requires a 2–4 week interval.
Does PDRN before laser improve the laser result?
There is a strong mechanistic case for pre-laser PDRN — improving baseline skin quality, collagen density, and the vascular supply to the tissue before the laser procedure creates a better starting point for the healing response. While large-scale RCT evidence for pre-laser PDRN specifically is limited, the wound healing evidence for PDRN and the collagen induction synergy are well-established. Most practitioners who offer this combination administer 1–2 PDRN sessions in the 4–6 weeks before the planned laser procedure as standard practice.
How many PDRN sessions are recommended after laser resurfacing?
For a standard fractional CO2 or erbium laser procedure, 4–6 PDRN sessions across the 6-month post-procedure remodelling window is the typical recommendation — monthly or 6-weekly from the first post-laser injection. For non-ablative procedures, the same frequency applies from week 2 onward. For HIFU, monthly sessions from week 1–2 through month 6. The number of sessions should be tailored to patient goals and budget — more sessions mean more biological amplification of the remodelling response.
Is there any interaction between PDRN and laser procedures?
There is no direct chemical or physical interaction between PDRN and any laser or energy device. They act through completely different mechanisms and at different tissue levels. The interaction concern is practical rather than chemical — the risk of injecting through compromised skin — which is managed by appropriate timing intervals. Once the skin is healed (for ablative procedures) or from the outset (for non-ablative and HIFU), there is no interaction of concern between PDRN and the energy device.
Can Korean PDRN products be used in post-laser protocols?
Yes — CE-marked Korean PDRN products from Celmade's PDRN and PN range are appropriate for post-laser protocols. CE marking confirms assessment against the same European medical device regulatory standards applicable to any injectable product. The post-procedure combination protocol relies on PDRN's biological mechanism (A2AR activation, VEGF angiogenesis, fibroblast support) — which is product-independent and consistent across all pharmaceutical-grade PDRN products at equivalent concentrations and molecular weight ranges.
